graphic-banner-01.jpg
 

A RARE VISION

Pioneering novel therapies to transform the treatment of protein misfolding diseases

 

News

Social Media

 
 

Clinical Trial Programme

We are currently investigating the safety and efficacy of arimoclomol in Niemann-Pick type C (NPC). NPC is a rare, lysosomal storage disorder which affects around 1 in 150,000 newborns.


Are you a patient, caregiver or healthcare professional? Do you need more information about our approach? We want to hear from you!  Click here to contact us.

Contact Us